Tolkatchev D, Ni F
Department of Biochemistry, McGill University, Montreal, Quebec, Canada.
Biochemistry. 1998 Jun 23;37(25):9091-100. doi: 10.1021/bi9730240.
Two different disulfide-paired isomers of the peptide T422DIDECENG430GFCSGVCHNL440PGTFECISG449, spanning the junction between the fifth and sixth EGF-like domains plus the N-terminal part of the sixth EGF-like domain from human thrombomodulin (TM), and containing a consensus calcium binding sequence, were synthesized and studied by two-dimensional proton NMR spectroscopy. In the course of air oxidation of the fully reduced form of the peptide, only uncrossed non EGF-like [1-2, 3-4] disulfide-bonded isomer was produced, regardless of the presence of redox buffer and/or calcium. The crossed [1-3, 2-4] isomer was prepared from a peptide with acetamidomethyl-protected second and fourth cysteines. The isomer with the crossed disulfide pairing was a better thrombin inhibitor and was more strongly affected by calcium binding than the uncrossed [1-2, 3-4] isomer. Calcium-induced NMR resonance shifts observed for the [1-3, 2-4] isomer provide evidence for the presence of a specific calcium-binding site in the corresponding TM region. There was a limited dispersion of the proton chemical shifts and a general lack of nonsequential NOE's for both peptide isomers in the presence or absence of calcium. Therefore, neither the apo nor the calcium-bound forms of the peptides adopted a completely folded conformation, despite the fact that the [1-3, 2-4] isomer contains a potential folding nucleus existing in a number of disulfide-rich proteins. Apparently, other interactions have to be involved to determine the three-dimensional structure of the criss-cross fold in this peptide, most likely the interaction with the C-terminal parts of the fifth and/or sixth EGF-like domains.
合成了肽T422DIDECENG430GFCSGVCHNL440PGTFECISG449的两种不同的二硫键配对异构体,该肽跨越人血栓调节蛋白(TM)的第五和第六个表皮生长因子(EGF)样结构域之间的连接点以及第六个EGF样结构域的N端部分,并包含一个共有钙结合序列,并用二维质子核磁共振波谱对其进行了研究。在该肽的完全还原形式的空气氧化过程中,无论是否存在氧化还原缓冲液和/或钙,只产生了未交叉的非EGF样[1-2, 3-4]二硫键连接异构体。交叉的[1-3, 2-4]异构体是由具有乙酰氨基甲基保护的第二个和第四个半胱氨酸的肽制备的。具有交叉二硫键配对的异构体是一种更好的凝血酶抑制剂,并且比未交叉的[1-2, 3-4]异构体受钙结合的影响更大。在[1-3, 2-4]异构体中观察到的钙诱导的核磁共振共振位移为相应的TM区域中存在特定的钙结合位点提供了证据。在有或没有钙的情况下,两种肽异构体的质子化学位移分散有限,并且普遍缺乏非顺序核Overhauser效应(NOE)。因此,尽管[1-3, 2-4]异构体包含许多富含二硫键的蛋白质中存在的潜在折叠核心,但肽的脱辅基形式和钙结合形式均未采用完全折叠的构象。显然,必须涉及其他相互作用来确定该肽中十字交叉折叠的三维结构,最有可能是与第五和/或第六个EGF样结构域的C端部分的相互作用。